<DOC>
	<DOCNO>NCT00384189</DOCNO>
	<brief_summary>The purpose study investigate efficacy inhale ciclesonide three different dose level compare placebo respect pulmonary function , asthma symptom , use rescue medication child age 6-11 year asthma . Treatment medication administer follow : ciclesonide placebo inhale daily evening . The study consist baseline period ( 2 4 week ) treatment period ( 12 week ) . The study provide data safety tolerability ciclesonide .</brief_summary>
	<brief_title>A Comparative Study Inhaled Ciclesonide Versus Placebo Children ( 6-11 Years ) With Asthma</brief_title>
	<detailed_description>The drug test call ciclesonide . This study look safety efficacy inhale ciclesonide child asthma . The study enrol 1080 patient . Participants randomly assign 1 4 treatment group undisclosed patient study doctor study : • Ciclesonide 40 µg , 80 µg 160 µg • Placebo- similar study drug active ingredient . Ciclesonide inhale via metered-dose inhaler ( MDI HFA-134a propellant ) , without spacer , daily even throughout study . All participant ask document daily AM PM peak expiratory flow ( PEF ) , daytime nighttime asthma symptom score number puff rescue medicine electronic diary . This multi-centre trial conduct worldwide . The overall time participate study 20 week . Participants make multiple visit clinic plus final visit 30 day last dose study drug follow-up assessment .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>Main History asthma least 6 month Ability show optimal use MDI , include inhalation technique Lung function reversibility within specify limit Main Concomitant severe disease Diseases contraindication use inhaled steroid Two inpatient hospitalization asthma within last year Respiratory tract infection asthma exacerbation within last 30 day prior entry study Use systemic steroid within last 30 day prior inclusion ( depot steroid 6 week ) Beginning change immunotherapy within last 6 month prior inclusion Inability follow procedure study</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Ciclesonide</keyword>
	<keyword>child</keyword>
</DOC>